Levur

Unlocking the next generation of oils, without the environmental impact

Personalise
Levur banner image

At a glance

  • Optimization graph line icon
    Development stage

    MVP developed

  • Cash payment coin 1 icon
    Investment stage

    Pre-Seed

  • Astronomy solar system icon
    UNSW affiliation

    Founders startup

  • Gauge dashboard icon
    Technology readiness level

    TRL 4

  • Gender female icon
    Female led

    Co-leadership

Why invest

Levur will disrupt the unsustainable oil industry with its proprietary technology platform and IP, built by a proven team and validated through global customer engagement.

Direct substitutes to palm and other unsustainable oils through a proprietary technology platform.

Levur’s proprietary synthetic biology platform enables development of sustainable alternatives to environmentally-destructive oils, such as palm. Oils are molecularly-identical, commercially-viable, scalable and integrate seamlessly into existing supply chains, accelerating customer adoption. With its technology, strong IP and highly-skilled team Levur will disrupt the $60B+ palm oil market.

  • Levur’s proprietary synthetic biology platform enables rapid-development of molecularly-identical, commercially viable and scalable sustainable oils.

    Global companies are actively seeking sustainable solutions to protect their businesses. Levur’s direct replacement oils enable manufacturers to switch to sustainable oil alternatives without cost-prohibitive changes to existing formulations, manufacturing facilities or supply chains.

    Levur generates revenue through direct oil sales, long-term licensing contracts of its proprietary IP, and high-value project‑based development services for targeted customer applications.

    • Palm oil is in 50% of grocery products and 70% of cosmetic products.
    • $60B+ palm oil industry contributes to deforestation, biodiversity loss and 0.5 billion tonnes of Co2 emissions annually.
    • Brands face regulatory and consumer pressure to find alternatives and meet demand. However, few viable drop-in replacements exist at scale.
    • Global consumer product manufacturers dependent on palm‑derived oils
    • Food ingredient and agribusiness companies (e.g. GrainCorp)
    • Oleochemical producers
    • Nutrition and specialty lipid companies
    • Biofuel producers and distributors
    • $1.2M pre-seed investment from Artesian GrainCorp Ventures and Main Sequence Ventures.
    • Planned trials with GrainCorp and Unilever Global
    • Signed contract with pharmaceutical company

Discover more UNSW spinouts

Search our catalogue of active spinouts and tech for license.